{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:34:36Z","timestamp":1789554876455,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ntt.2012.07.001","type":"journal-article","created":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T06:13:26Z","timestamp":1341814406000},"page":"489-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat"],"prefix":"10.1016","volume":"34","author":[{"given":"Mohammad Hossein","family":"Esmaeili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayda","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem","family":"Haghdoost-Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0306-4522(97)00498-3","article-title":"Behavioural recovery after unilateral lesion of the dopaminergic mesotelencephalic pathway: effect of repeated testing","volume":"84","author":"Abrous","year":"1998","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-3940(83)90548-7","article-title":"Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity","volume":"35","author":"Bevan","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ntt.2012.07.001_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.neuroscience.2004.05.002","article-title":"The strong inhibition of triosephosphate isomerase by the natural \u03b2-carbolines may explain their neurotoxic actions","volume":"127","author":"Bonnet","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(95)00150-O","article-title":"Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test","volume":"676","author":"Borlongan","year":"1995","journal-title":"Brain Res"},{"issue":"17","key":"10.1016\/j.ntt.2012.07.001_bb0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0024-3205(96)00112-9","article-title":"Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking","volume":"58","author":"Breyer-Pfaff","year":"1996","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.ntt.2012.07.001_bb0030","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.ntt.2012.07.001_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(92)90576-U","article-title":"Indole-N-methylated \u03b2-carbolinium ions as potential brain-bioactivated toxins","volume":"505","author":"Collins","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.ntt.2012.07.001_bb0040","first-page":"171","article-title":"b-Carbolines: metabolism and neurotoxicity","volume":"12","author":"Collins","year":"1996","journal-title":"Biogenic Amines"},{"key":"10.1016\/j.ntt.2012.07.001_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0892-0362(02)00210-6","article-title":"Potential neurotoxic \u201cagents provocateurs\u201d in Parkinson's disease","volume":"24","author":"Collins","year":"2002","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0028-3908(71)90004-9","article-title":"An investigation on the central effects of harmine, harmaline and related beta-carbolines","volume":"10","author":"Fuentes","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ntt.2012.07.001_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0169-328X(96)00018-6","article-title":"Expression of dopamine transporter mRNA and its binding site in fetal nigral cells transplanted into the striatum of 6-OHDA lesioned rat","volume":"39","author":"Fujita","year":"1996","journal-title":"Mol Brain Res"},{"issue":"7","key":"10.1016\/j.ntt.2012.07.001_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0197-0186(01)00115-2","article-title":"Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease","volume":"40","author":"Gearhart","year":"2002","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2010.07.011","article-title":"Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels","volume":"215","author":"Haghdoost-Yazdi","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0070","first-page":"260","article-title":"Norharman exacerbates 6-hydroxydopamine-induced Parkinson's disease but cannot establish it alone","volume":"15","author":"Haghdoost-Yazdi","year":"2011","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ntt.2012.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1471-4159.2006.03940.x","article-title":"Neurotoxic mechanisms of 2,9-dimethyl-b-carbolinium ion in primary dopaminergic culture","volume":"98","author":"Hamann","year":"2006","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2004.11.033","article-title":"Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors","volume":"326","author":"Herraiz","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ntt.2012.07.001_bb0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/02652030210145892","article-title":"Identification and occurrence of the bioactive betacarbolines norharman and harman in coffee brews","volume":"19","author":"Herraiz","year":"2002","journal-title":"Food Addit Contam"},{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.ntt.2012.07.001_bb0095","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.0953-816x.2001.01563.x","article-title":"Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells","author":"Kim","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-3057(93)90370-9","article-title":"Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum","volume":"46","author":"Klug","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ntt.2012.07.001_bb0105","first-page":"291","article-title":"Plasma harman and norharman in Parkinson's disease","volume":"46","author":"Kuhn","year":"1995","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.ntt.2012.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/BF01271257","article-title":"Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients","volume":"103","author":"Kuhn","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ntt.2012.07.001_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1471-4159.2000.0750521.x","article-title":"Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells","volume":"75","author":"Lee","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.ntt.2012.07.001_bb0120","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1523\/JNEUROSCI.16-20-06394.1996","article-title":"The role of monoamine metabolism in oxidative glutamate toxicity","volume":"16","author":"Maher","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.ntt.2012.07.001_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0892-0362(02)00212-X","article-title":"N-methylation underlying Parkinson's disease","volume":"24","author":"Matsubara","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ntt.2012.07.001_bb0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1471-4159.1998.70020727.x","article-title":"Endogenously occurring b-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease","volume":"70","author":"Matsubara","year":"1998","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.ntt.2012.07.001_bb0135","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1212\/WNL.45.12.2240","article-title":"beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease","volume":"45","author":"Matsubara","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.1991.tb08177.x","article-title":"[3H] harman binding experiments. I: a reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat","volume":"56","author":"May","year":"1991","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.ntt.2012.07.001_bb0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0892-0362(02)00209-X","article-title":"Amine-related neurotoxins in Parkinson's disease: past, present, and future","volume":"24","author":"Nagatsu","year":"2002","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"10.1016\/j.ntt.2012.07.001_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-003-0080-0","article-title":"Long-term retention of neurotoxic beta-carbolines in brain neuromelanin","volume":"111","author":"Ostergren","year":"2004","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.ntt.2012.07.001_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00702-005-0334-0","article-title":"Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra","volume":"113","author":"Ostergren","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ntt.2012.07.001_bb0160","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.neuroscience.2006.01.018","article-title":"2,9-Dimethyl-b-carbolinium, a neurotoxin occuring in human brain, is an equipotent apoptotic inducer as 1-methyl-4-phenylpyridinium (MPP+)","volume":"139","author":"Pavlovic","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ntt.2012.07.001_bb0165","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.ntt.2012.07.001_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchromb.2003.10.044","article-title":"Exposure to beta-carbolines norharman and harman","volume":"802","author":"Pfau","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.ntt.2012.07.001_bb0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0014-4886(87)90231-7","article-title":"Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs","volume":"96","author":"Pranzatelli","year":"1987","journal-title":"Exp Neurol"},{"issue":"4\u20135","key":"10.1016\/j.ntt.2012.07.001_bb0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiol Behav"},{"issue":"1\u20132","key":"10.1016\/j.ntt.2012.07.001_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)01452-8","article-title":"The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets","volume":"441","author":"Rommelspacher","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.ntt.2012.07.001_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0014-2999(81)90173-4","article-title":"Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo","volume":"70","author":"Rommelspacher","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ntt.2012.07.001_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","article-title":"An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism","volume":"2","author":"Rozas","year":"1997","journal-title":"Brain Res Brain Res Protoc"},{"key":"10.1016\/j.ntt.2012.07.001_bb0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.bjp.0706024","article-title":"Modulation of voltage-gated channel currents by harmaline and harmane","volume":"144","author":"Splettstoesser","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ntt.2012.07.001_bb0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1471-4159.2004.02397.x","article-title":"Dopamine transporter-mediated cytotoxicity of \u00df-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake","volume":"89","author":"Storch","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.ntt.2012.07.001_bb0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-2952(91)90305-O","article-title":"Antioxidative properties of harmane and b-carboline alkaloids","volume":"42","author":"Tse","year":"1991","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.ntt.2012.07.001_bb0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"15;144","author":"Yuan","year":"2005","journal-title":"J Neurosci Methods"}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036212001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036212001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:17:34Z","timestamp":1760210254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036212001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0892036212001250"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2012.07.001","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2012.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}